mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease

被引:26
|
作者
Matboli, Marwa [1 ]
Gadallah, Shaimaa H. [2 ]
Rashed, Wafaa M. [3 ]
Hasanin, Amany Helmy [4 ]
Essawy, Nada [5 ]
Ghanem, Hala M. [2 ]
Eissa, Sanaa [1 ]
机构
[1] Ain Shams Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo 11382, Egypt
[2] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo 11382, Egypt
[3] Childrens Canc Hosp 57357, Dept Res, Cairo 11382, Egypt
[4] Ain Shams Univ, Fac Med, Dept Clin Pharmacol, Cairo 11382, Egypt
[5] Inst Pasteur, F-75724 Paris 15, France
关键词
NAFLD; Non-Alcoholic SteatoHepatitis (NASH); Hippo signaling; miRNAs; lncRNAs; ncRNAs network; HIPPO SIGNALING PATHWAY; TRANSCRIPTION FACTORS; GENE-EXPRESSION; LIPID-METABOLISM; SIZE-CONTROL; PROGRESSION; HOMEOSTASIS; FIBROSIS; BIOINFORMATICS; TUMORIGENESIS;
D O I
10.3390/ijms22136770
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aim: we aimed to construct a bioinformatics-based co-regulatory network of mRNAs and non coding RNAs (ncRNAs), which is implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), followed by its validation in a NAFLD animal model. Materials and Methods: The mRNAs-miRNAs-lncRNAs regulatory network involved in NAFLD was retrieved and constructed utilizing bioinformatics tools. Then, we validated this network using an NAFLD animal model, high sucrose and high fat diet (HSHF)-fed rats. Finally, the expression level of the network players was assessed in the liver tissues using reverse transcriptase real-time polymerase chain reaction. Results: in-silico constructed network revealed six mRNAs (YAP1, FOXA2, AMOTL2, TEAD2, SMAD4 and NF2), two miRNAs (miR-650 and miR-1205), and two lncRNAs (RPARP-AS1 and SRD5A3-AS1) that play important roles as a co-regulatory network in NAFLD pathogenesis. Moreover, the expression level of these constructed network-players was significantly different between NAFLD and normal control. Conclusion and future perspectives: this study provides new insight into the molecular mechanism of NAFLD pathogenesis and valuable clues for the potential use of the constructed RNA network in effective diagnostic or management strategies of NAFLD.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
    Ragab, Halla M.
    Ezzat, Wafaa M.
    Hassan, Eman Mahmoud
    El Maksoud, Nabila Abd
    Afify, Mie
    Abd El-Maksoud, Mohamed D. E.
    Elaziz, Wafaa Abd
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2023, 21 (01)
  • [42] COFFEE AND NONALCOHOLIC FATTY LIVER DISEASE: A REVIEW
    Nikrandt, Grzegorz
    Chmurzynska, Agata
    ACTA SCIENTIARUM POLONORUM-TECHNOLOGIA ALIMENTARIA, 2020, 19 (03) : 245 - 254
  • [43] How to Diagnose Nonalcoholic Fatty Liver Disease
    de Alwis, Nimantha M. W.
    Anstee, Quentin M.
    Day, Christopher P.
    DIGESTIVE DISEASES, 2016, 34 : 19 - 26
  • [44] Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?
    Shen, Xiang
    Yu, Ziqi
    Wei, Changli
    Hu, Chong
    Chen, Jianyong
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2024, 326 (06): : E767 - E775
  • [45] Artificial intelligence in nonalcoholic fatty liver disease
    Mahzari, Ali
    EGYPTIAN LIVER JOURNAL, 2022, 12 (01)
  • [46] Innate immunity and nonalcoholic fatty liver disease
    Kountouras, Jannis
    Kazakos, Evangelos
    Kyrailidi, Foteini
    Polyzos, Stergios A.
    Zavos, Christos
    Arapoglou, Stergios
    Boziki, Marina
    Mouratidou, Maria C.
    Tzitiridou-Chatzopoulou, Maria
    Chatzopoulos, Dimitrios
    Doulberis, Michael
    Papaefthymiou, Apostolis
    Vardaka, Elisabeth
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (03): : 244 - 256
  • [47] Recent Epidemiology of Nonalcoholic Fatty Liver Disease
    Murag, Soumya
    Ahmed, Aijaz
    Kim, Donghee
    GUT AND LIVER, 2021, 15 (02) : 206 - 216
  • [48] DNA Methylation in Nonalcoholic Fatty Liver Disease
    Hyun, Jeongeun
    Jung, Youngmi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 26
  • [49] Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
    Castera, Laurent
    Friedrich-Rust, Mireen
    Loomba, Rohit
    GASTROENTEROLOGY, 2019, 156 (05) : 1264 - +
  • [50] Lipidomics in human nonalcoholic fatty liver disease
    Buechler, Christa
    CLINICAL LIPIDOLOGY, 2014, 9 (03) : 279 - 282